Mon, Jul 14, 2014, 7:09 AM EDT - U.S. Markets open in 2 hrs 21 mins

Recent

% | $
Quotes you view appear here for quick access.

Momenta Pharmaceuticals Inc. Message Board

  • froy99_99 froy99_99 Dec 11, 2011 8:51 PM Flag

    MNTA 'ReadMeFirst' updated:

    Sanofi “un-launches” Lovenox authorized generic;
    NVS-MNTA contract has no provision to revert to pre-AG mode;
    table of monthly branded and generic Lovenox scripts;
    chronology of Lovenox pricing changes Sep 2011 to present;
    appeal of Lovenox PI scheduled for 1/24/12;
    FDA approves NVS/MNTA’s vial formulation of Lovenox;
    2012-2013 news flow (new info re appeal of Lovenox PI);
    transcript of Deutsche Bank webcast (12/5/11);
    handicapping the Copaxone ANDA (revised);
    MNTA acquires ‘sialic switch’ IP from Virdante Pharmaceuticals;
    musings on the Virdante acquisition;
    US patent-expiration dates for large-selling biologics;
    recent patent applications and overview of IP estate;
    new version of “What’s New in the Anticoagulant Arena?

    http://investorshub.advfn.com/boards/read_msg.aspx?message_id=69823153

 
MNTA
11.73+0.30(+2.62%)Jul 11 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.